Cargando…

Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital

We investigated the antibiotic susceptibility of glycopeptide-resistant enterococci (GRE). Seventy consecutive GRE were tested. Sixty-two isolates were identified as Enterococcus faecium (88.6%), and 8 (11.4%) as Enterococcus faecalis. All strains were susceptible to linezolid and daptomycin, while...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maraki, Sofia, Samonis, George, Dimopoulou, Dimitra, Mantadakis, Elpis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2014
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285005/ https://www.ncbi.nlm.nih.gov/pubmed/25566405 http://dx.doi.org/10.3947/ic.2014.46.4.253

Ejemplares similares

The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020)

Quinupristin/Dalfopristin-induced Sweet’s Syndrome
por: Choi, Hye Sook, et al.
Publicado: (2003)

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
por: El-Azizi, Mohamed, et al.
Publicado: (2005)

Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin
por: Hussain, Khandakar, et al.
Publicado: (2016)

Quinupristin/dalfopristin in Staphylococcus aureus endophthalmitis: a case report
por: Hernandez-Da Mota, Sergio E
Publicado: (2011)

A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital
por: Maraki, Sofia, et al.
Publicado: (2016)

Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China
por: Wang, Shanshan, et al.
Publicado: (2016)

The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism
por: Shaw, Timothy D., et al.
Publicado: (2018)

Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin
por: Harms, Jörg M, et al.
Publicado: (2004)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections
por: Dimopoulou, Dimitra, et al.
Publicado: (2023)

Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge
por: Neonakis, Ioannis, et al.
Publicado: (2006)

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
por: McKinnell, James A., et al.
Publicado: (2015)

Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
por: Eckmann, Christian, et al.
Publicado: (2010)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States
por: Gargis, Amy S., et al.
Publicado: (2022)

Antimicrobial Activity of Dalbavancin Tested against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from United States (US) Medical Centers
por: Sader, Helio S, et al.
Publicado: (2017)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India
por: Chitnis, Sheetal, et al.
Publicado: (2013)

Validating a screening agar for linezolid-resistant enterococci
por: Werner, Guido, et al.
Publicado: (2019)

The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections
por: Fu, Jinjian, et al.
Publicado: (2013)

Venetian Rule and Control of Plague Epidemics on the Ionian Islands during 17th and 18th Centuries
por: Konstantinidou, Katerina, et al.
Publicado: (2009)

Characterization of Clinical Isolates of Enterococci with Special Reference to Glycopeptide Susceptibility at a Tertiary Care Center of Eastern Nepal
por: Karna, Aasish, et al.
Publicado: (2019)

The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis
por: Dadashi, Masoud, et al.
Publicado: (2021)

Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs
por: Birgand, Gabriel, et al.
Publicado: (2013)

Acquisition of Daptomycin Resistance by Enterococcus faecium Confers Collateral Sensitivity to Glycopeptides
por: Zeng, Weiliang, et al.
Publicado: (2022)

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci
por: Kainer, Marion A., et al.
Publicado: (2007)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

In Vitro Activity of Rifampicin Combined with Daptomycin or Tigecycline on Staphylococcus haemolyticus Biofilms
por: Szczuka, Ewa, et al.
Publicado: (2015)

The Role of Subinhibitory Concentrations of Daptomycin and Tigecycline in Modulating Virulence in Staphylococcus aureus
por: Atshan, Salman Sahab, et al.
Publicado: (2021)

Molecular Characterization of Glycopeptide-Resistant Enterococci from Hospitals of the Picardy Region (France)
por: Biendo, M., et al.
Publicado: (2010)

Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021)

Quinpristin-Dalfopristin resistance among methicillin-resistant strains of staphylococci
por: Bhatawadekar, S., et al.
Publicado: (2010)

Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2021)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
por: Wingler, Mary Joyce, et al.
Publicado: (2021)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
por: Pincus, Nathan B., et al.
Publicado: (2022)

Evaluation of Susceptibility of Glycopeptide-resistant and Glycopeptide-sensitive Enterococci to Commonly Used Biocides in a Super-speciality Hospital: A Pilot Study
por: Bhatia, Mohit, et al.
Publicado: (2017)

Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
por: Mishra, Nagendra N., et al.
Publicado: (2012)

Factors associated with acquisition of glycopeptide-resistant enterococci during a single-strain outbreak
por: Deboscker, S., et al.
Publicado: (2019)

Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome
por: Samonis, George, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5gu70fisjd1mbqeece8nvfreuj